InsideTrading SEC Form 4 insider trades
← All clusters
XFOR

X4 Pharmaceuticals, Inc

Healthcare Biological Products, (No Diagnostic Substances) Market cap: $309.3M Ticker page → Watch XFOR (just your e-mail) Price alert (just your e-mail)

Limited buying: $33.2M bought (counted up to $5.0M); 9 distinct insiders. Holding it back: largest buyer: GORDON CARL L (Director), 15% of the dollars.

55
Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation. <60 · limited buying
–
Since the cluster formed, vs benchmark

Score, not a recommendation.

Total bought$33.2M17 Form 4 purchases
Distinct insiders9open-market buyers
Insiders' average price$10.00no price on the purchase days
Cluster window2017-11-20single day · closed

partial dataAn input is missing, usually the market cap or the price history. A missing input counts as neutral in the score and is never estimated. Price history is incomplete; missing inputs count as neutral in the score.

same price, one day All 17 purchases were at $10.00 on 2017-11-20. That pattern also occurs in IPO or conversion subscriptions, which are not open-market conviction buying.

Price and insider purchases

Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.

Loading price history…

How the score adds up

How each input is counted →
Points each input adds to the score, and how much of the points it could give it has
Input Strength Points
$33.2M bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. 100% +57
9 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. 95% +14
No CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. 0% +0
Stock 0% below its 1-year highHow far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. 0% +0
0 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. 100% +0
Routine or plan purchases: 0% of the dollarsThe share of the dollars in routine or plan purchases (a Rule 10b5-1 plan, dividend reinvestment, a regular cadence). All of it routine would take off 5.6 points. 100% +0
Largest buyer: GORDON CARL L (Director), 15% of the dollarsThe share of the dollars bought by the largest buyer. Buying spread evenly keeps the points; one buyer paying for everything takes off 12.7. 96% -2
Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast.69
Pipeline flagsPoints taken off because the filings themselves show this buying was an offering, a plan or a 10b5-1 programme. Used only when there is no AI review; from Form 4 footnotes, 8-K filings and prices. (IPO or offering)-14
Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation.55

Why are they buying?

No explanation has been generated for this cluster. The filings in the table below are the primary evidence.

Transactions

17 Form 4 trades · 9 insiders Download CSV Up to 5,000 rows
Purchases in this cluster, grouped by insider, largest first
Date InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. Role Shares Price Value Filing
2017-11-20 Ross Michael Jay history of Ross Michael Jay's purchases Director 500,000 $10.00 avg $5.0M
2017-11-20 Ross Michael Jay 483,448 $10.00 $4.8M SEC filing for Ross Michael Jay (opens in a new tab)
2017-11-20 Ross Michael Jay 16,552 $10.00 $165.5K SEC filing for Ross Michael Jay (opens in a new tab)
2017-11-20 Flint Jonathan A history of Flint Jonathan A's purchases 10% owner 500,000 $10.00 avg $5.0M
2017-11-20 Flint Jonathan A 482,467 $10.00 $4.8M SEC filing for Flint Jonathan A (opens in a new tab)
2017-11-20 Flint Jonathan A 9,403 $10.00 $94.0K SEC filing for Flint Jonathan A (opens in a new tab)
2017-11-20 Flint Jonathan A 3,305 $10.00 $33.0K SEC filing for Flint Jonathan A (opens in a new tab)
2017-11-20 Flint Jonathan A 4,825 $10.00 $48.2K SEC filing for Flint Jonathan A (opens in a new tab)
2017-11-20 GORDON CARL L history of GORDON CARL L's purchases Director 500,000 $10.00 $5.0M SEC filing for GORDON CARL L (opens in a new tab)
2017-11-20 MCGUIRE TERRANCE history of MCGUIRE TERRANCE's purchases Director 500,000 $10.00 avg $5.0M
2017-11-20 MCGUIRE TERRANCE 482,467 $10.00 $4.8M SEC filing for MCGUIRE TERRANCE (opens in a new tab)
2017-11-20 MCGUIRE TERRANCE 9,403 $10.00 $94.0K SEC filing for MCGUIRE TERRANCE (opens in a new tab)
2017-11-20 MCGUIRE TERRANCE 3,305 $10.00 $33.0K SEC filing for MCGUIRE TERRANCE (opens in a new tab)
2017-11-20 MCGUIRE TERRANCE 4,825 $10.00 $48.2K SEC filing for MCGUIRE TERRANCE (opens in a new tab)
2017-11-20 SV LIFE SCIENCES FUND V LP history of SV LIFE SCIENCES FUND V LP's purchases 10% owner 500,000 $10.00 avg $5.0M
2017-11-20 SV LIFE SCIENCES FUND V LP 483,448 $10.00 $4.8M SEC filing for SV LIFE SCIENCES FUND V LP (opens in a new tab)
2017-11-20 SV LIFE SCIENCES FUND V LP 16,552 $10.00 $165.5K SEC filing for SV LIFE SCIENCES FUND V LP (opens in a new tab)
2017-11-20 Nessi Claudio history of Nessi Claudio's purchases Director 300,000 $10.00 $3.0M SEC filing for Nessi Claudio (opens in a new tab)
2017-11-20 NeoMed Innovation V L.P. history of NeoMed Innovation V L.P.'s purchases 10% owner 300,000 $10.00 $3.0M SEC filing for NeoMed Innovation V L.P. (opens in a new tab)
2017-11-20 Gerngross Tillman U. history of Gerngross Tillman U.'s purchases Director 200,000 $10.00 $2.0M SEC filing for Gerngross Tillman U. (opens in a new tab)
2017-11-20 Muhlenbeck Frank history of Muhlenbeck Frank's purchases 10% owner 20,000 $10.00 $200.0K SEC filing for Muhlenbeck Frank (opens in a new tab)
Total $33.2M